The role of high cell density in the promotion of neuroendocrine transdifferentiation of prostate cancer cells

por Pernicová, Zuzana, Slabáková, Eva, Fedr, Radek, Šimečková, Šárka, Jaroš, Josef, Suchánková, Tereza, Bouchal, Jan, Kharaishvili, Gvantsa, Král, Milan, Kozubík, Alois, Souček, Karel
Publicado 2014

High Skp2 expression is associated with a mesenchymal phenotype and increased tumorigenic potential of prostate cancer cells

por Šimečková, Šárka, Kahounová, Zuzana, Fedr, Radek, Remšík, Ján, Slabáková, Eva, Suchánková, Tereza, Procházková, Jiřina, Bouchal, Jan, Kharaishvili, Gvantsa, Král, Milan, Beneš, Petr, Souček, Karel
Publicado 2019

Opposite regulation of MDM2 and MDMX expression in acquisition of mesenchymal phenotype in benign and cancer cells

por Slabáková, Eva, Kharaishvili, Gvantsa, Smějová, Monika, Pernicová, Zuzana, Suchánková, Tereza, Remšík, Ján, Lerch, Stanislav, Straková, Nicol, Bouchal, Jan, Král, Milan, Culig, Zoran, Kozubík, Alois, Souček, Karel
Publicado 2015

The CHK1 inhibitor MU380 significantly increases the sensitivity of human docetaxel‐resistant prostate cancer cells to gemcitabine through the induction of mitotic catastrophe

por Drápela, Stanislav, Khirsariya, Prashant, van Weerden, Wytske M., Fedr, Radek, Suchánková, Tereza, Búzová, Diana, Červený, Jan, Hampl, Aleš, Puhr, Martin, Watson, William R., Culig, Zoran, Krejčí, Lumír, Paruch, Kamil, Souček, Karel
Publicado 2020

MEK inhibitors block growth of lung tumours with mutations in ataxia–telangiectasia mutated

por Smida, Michal, Fece de la Cruz, Ferran, Kerzendorfer, Claudia, Uras, Iris Z., Mair, Barbara, Mazouzi, Abdelghani, Suchankova, Tereza, Konopka, Tomasz, Katz, Amanda M., Paz, Keren, Nagy-Bojarszky, Katalin, Muellner, Markus K., Bago-Horvath, Zsuzsanna, Haura, Eric B., Loizou, Joanna I., Nijman, Sebastian M. B.
Publicado 2016